Tango Therapeutics, Inc. (TNGX) Insider Trading -- Recent Executive & Director Transactions

14 insiders reported 69 Form 4 transactions for Tango Therapeutics, Inc. (TNGX) over the past 18 months (most recent 2026-07-02). Recent activity: Crystal Adam (President, R&D) Buy 27,000 shares, Crystal Adam (President, R&D) Sell 19,629 shares, Crystal Adam (President, R&D) Sell 7,371 shares, Azelby Robert (Director) Buy 5,740 shares, Calhoun Lesley Ann (Director) Buy 4,000 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-07-02Crystal AdamPresident, R&DBuy27,000$140,400
2026-07-02Crystal AdamPresident, R&DSell19,629$575,962
2026-07-02Crystal AdamPresident, R&DSell7,371$222,946
2026-06-23Azelby RobertDirectorBuy5,740$0
2026-06-08Calhoun Lesley AnnDirectorBuy4,000$0
2026-06-08Lee SungDirectorBuy570$0
2026-06-08Rothenberg MaceDirectorBuy4,000$0
2026-06-08Ketchum John BDirectorBuy4,000$0
2026-06-03Crystal AdamPresident, R&DBuy27,000$140,400
2026-06-03Crystal AdamPresident, R&DSell6,140$136,627
2026-06-03Crystal AdamPresident, R&DSell20,860$480,944
2026-05-01Lee SungDirectorBuy12,300$0
2026-04-16Crystal AdamPresident, R&DBuy38,460$199,992
2026-04-16Crystal AdamPresident, R&DSell38,460$961,500
2026-04-02Crystal AdamPresident, R&DBuy27,000$140,400
2026-04-02Crystal AdamPresident, R&DSell27,000$572,478
2026-03-27Crystal AdamPresident, R&DBuy12,000$62,400
2026-03-27Crystal AdamPresident, R&DSell12,000$241,320
2026-03-09Crystal AdamPresident, R&DSell20,251$303,765
2026-02-27Crystal AdamPresident, R&DSell54,345$693,986
2026-02-04Crystal AdamPresident, R&DBuy47,460$0
2026-02-04Crystal AdamPresident, R&DSell18,251$223,757
2026-02-04Crystal AdamPresident, R&DSell201$2,593
2026-02-04Beckman DaniellaChief Financial OfficerBuy44,330$0
2026-02-04Beckman DaniellaChief Financial OfficerSell10,204$125,101

Source: SEC Form 4 filings · as of 2026-07-02